1-4 of 4
Marc Ernstoff
Close
Sort by
Journal Articles

NKG2D, An NK Cell Activating Receptor on CD8 + T Cells, Plays An Essential Role In Killing Myeloma Cells

Laleh Talebian, PhD, Kenneth Meehan, MD, Megan E Patey, Dawn A Fisher, B.S., Zbigniew Szczepiorkowski, MD, PhD, Marc Ernstoff, Charles Sentman
Journal: Blood
Blood (2010) 116 (21): 2087.
https://doi.org/10.1182/blood.V116.21.2087.2087
Published: 2010
Journal Articles

Immune Mobilization with IL-2 and Growth Factors: Differential in Vivo Effects of the NKG2D Receptor on CD8+ and CD56+ Effector Cells

Kenneth R Meehan, MD, John M. Hill, Jr., MD, Marc Ernstoff, MD, Charles L Sentman, MD
Journal: Blood
Blood (2008) 112 (11): 3491.
https://doi.org/10.1182/blood.V112.11.3491.3491
Published: 2008
Journal Articles

Large Scale Expansion of Activated T Cells: Defining Procedures and Cryopreservation Methods for Clinical Use as Adoptive Cellular Therapy Post-Transplant.

Jia-Yan Wu, PhD, Susan M. Webber, BS MT(ASAP) BB, John M. Hill, MD, Marc Ernstoff, MD, Zbigniew Szczepiorkowski, MD, PhD, Kenneth R. Meehan, MD
Journal: Blood
Blood (2006) 108 (11): 5232.
https://doi.org/10.1182/blood.V108.11.5232.5232
Published: 2006
Journal Articles

The Critical Role of the NKG2D Receptor in CD8+CTL and CD8+CD56+ NKT Cell Cytotoxicity.

Jia-Yan Wu, Ph.D, John M. Hill, MD, Marc Ernstoff, MD, Kenneth R. Meehan
Journal: Blood
Blood (2004) 104 (11): 3164.
https://doi.org/10.1182/blood.V104.11.3164.3164
Published: 2004